# ![@JessieChimni Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::2561940434.png) @JessieChimni Jasbinder (Jessie) Chimni (My Opinions only)

Jasbinder (Jessie) Chimni (My Opinions only) posts on X about $crsp, $fate, $ipsc, $sana the most. They currently have [------] followers and [---] posts still getting attention that total [------] engagements in the last [--] hours.

### Engagements: [------] [#](/creator/twitter::2561940434/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2561940434/c:line/m:interactions.svg)

- [--] Week [-----] -53%
- [--] Month [------] +129%
- [--] Months [-------] -34%
- [--] Year [-------] +13%

### Mentions: [--] [#](/creator/twitter::2561940434/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2561940434/c:line/m:posts_active.svg)

- [--] Week [--] -16%
- [--] Month [---] +214%
- [--] Months [---] +20%
- [--] Year [---] +64%

### Followers: [------] [#](/creator/twitter::2561940434/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2561940434/c:line/m:followers.svg)

- [--] Week [-----] no change
- [--] Month [-----] +0.03%
- [--] Months [-----] +1.10%
- [--] Year [-----] +14%

### CreatorRank: [---------] [#](/creator/twitter::2561940434/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2561940434/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  49.63% [automotive brands](/list/automotive-brands)  17.04% [finance](/list/finance)  14.07% [cryptocurrencies](/list/cryptocurrencies)  8.15% [countries](/list/countries)  5.93% [technology brands](/list/technology-brands)  2.22% [celebrities](/list/celebrities)  1.48% [social networks](/list/social-networks)  1.48% [travel destinations](/list/travel-destinations)  0.74% [financial services](/list/financial-services)  0.74%

**Social topic influence**
[$crsp](/topic/$crsp) #15, [$fate](/topic/$fate) #7, [$ipsc](/topic/$ipsc) #12, [$sana](/topic/$sana) 11.11%, [$tsla](/topic/$tsla) 9.63%, [tesla](/topic/tesla) 9.63%, [data](/topic/data) 8.15%, [$lctx](/topic/$lctx) #3, [$ntla](/topic/$ntla) 7.41%, [$acet](/topic/$acet) #4

**Top accounts mentioned or mentioned by**
[@geneinvesting](/creator/undefined) [@ny197247](/creator/undefined) [@ny1972_47](/creator/undefined) [@yaireinhorn](/creator/undefined) [@thecellengineer](/creator/undefined) [@crisprsam](/creator/undefined) [@skathire](/creator/undefined) [@ascendingbio](/creator/undefined) [@mohamed42146618](/creator/undefined) [@ctamaga](/creator/undefined) [@robotaxi](/creator/undefined) [@tesla](/creator/undefined) [@biomedicalrx](/creator/undefined) [@collision](/creator/undefined) [@bradloncar](/creator/undefined) [@biotechch](/creator/undefined) [@davidrliu](/creator/undefined) [@elilillyandco](/creator/undefined) [@biostocks](/creator/undefined) [@stocktwits](/creator/undefined)

**Top assets mentioned**
[CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Century Therapeutics, Inc. (IPSC)](/topic/$ipsc) [Sana Biotechnology, Inc. (SANA)](/topic/$sana) [Tesla, Inc. (TSLA)](/topic/$tsla) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [Verve Therapeutics Inc. (VERV)](/topic/$verv) [BEAM (BEAM)](/topic/$beam) [Vertex Protocol (VRTX)](/topic/$vrtx) [Caribou Biosciences, Inc. (CRBU)](/topic/$crbu) [Eli Lilly and Company (LLY)](/topic/$lly) [Lemonade, Inc. (LMND)](/topic/$lmnd) [Prime Medicine, Inc. (PRME)](/topic/$prme) [Absci Corporation (ABSI)](/topic/$absi) [Allora (ALLO)](/topic/$allo) [Pfizer, Inc. (PFE)](/topic/$pfe) [Goldman Sachs (GS)](/topic/goldman-sachs) [ArbitrageCT (ARCT)](/topic/$arct) [Born in [--] (19)](/topic/$19)
### Top Social Posts
Top posts by engagements in the last [--] hours

"I know of three CAR-T companies that are expected to start pivotal trials in AID in 2026: 1) $CABA - CD19 Autologous CAR-T (H1 2026) 2) $ACET - CD20 Allogenic CAR-T donor derived (H2-2026) 3) $FATE - CD19 Allogenic CAR-T iPSC derived (H2-2026) [----] should be the start of the transformation of treatment for AID. Assuming good data they should file by BLA H1 [----]. #Genomics #Cure #AutoImmuneDisease https://twitter.com/i/web/status/2009077584680845723 https://twitter.com/i/web/status/2009077584680845723"  
[X Link](https://x.com/JessieChimni/status/2009077584680845723)  2026-01-08T01:39Z [----] followers, [----] engagements


"Next conference us EULAR June 3-6 in London. May be they will provide an update then but it is pretty far. Let's see. I am looking forward to hearing updates from $ACET and $CABA on Feb [--] at Guggenheim Emerging Outlook: Biotech Summit [----] https://twitter.com/i/web/status/2019941273294238080 https://twitter.com/i/web/status/2019941273294238080"  
[X Link](https://x.com/JessieChimni/status/2019941273294238080)  2026-02-07T01:08Z [----] followers, [---] engagements


"Another new [--] week high for $IPSC. This one has the potential to be a100 bagger if [---] is successful. The journey will be long and turbulent as with any biotech investment. I am long and will hold thru [---] commercialization. NFA"  
[X Link](https://x.com/JessieChimni/status/2015867343029805160)  2026-01-26T19:20Z [----] followers, [---] engagements


"@BiomedicalRX The good part is that even if they enter the clinic in [----] thats good enough. The TAM is huge and options are limited. $SANA $CRSP $IPSC $LCTX $VRTX"  
[X Link](https://x.com/JessieChimni/status/2015905798178935103)  2026-01-26T21:52Z [----] followers, [---] engagements


"@GeneInvesting I am at my max allocation unfortunately. I was stupid with $PRME and $IPSC when they were at their lows. oh well.live and learn"  
[X Link](https://x.com/JessieChimni/status/2017351686130647090)  2026-01-30T21:38Z [----] followers, [---] engagements


"@yaireinhorn @collision @skathire @bradloncar @BiotechCH @davidrliu @EliLillyandCo @BioStocks @Stocktwits @Maximus_Holla @BrandonVanZee & $IPSC"  
[X Link](https://x.com/JessieChimni/status/2017709802487730534)  2026-01-31T21:21Z [----] followers, [---] engagements


"They will have a challenge when allo companies target the same indication. $FATE can produce [-----] doses a year $CRSP can produce [-----] and $ACET should be similar to $CRSP. My assumption is that $FATE and $ACET will start pivotal in myositis/SSc in [----]. I am long $FATE and $CRSP and have a small exposure to $ACET. $FATE remains my favorite company targeting AID. Will add to the position if/when they file BLA or are closer to FDA approval. Upside potential is large post commercialization of [---]. NFA https://twitter.com/i/web/status/2018075121840492603"  
[X Link](https://x.com/JessieChimni/status/2018075121840492603)  2026-02-01T21:32Z [----] followers, [--] engagements


"@AscendingBio @thecellengineer @Octopusking77 No $ACET already shared good data for [--] patients in SLE/LN"  
[X Link](https://x.com/JessieChimni/status/2018350584823468310)  2026-02-02T15:47Z [----] followers, [---] engagements


"1345 from your list for [----]. Plus 6) Update from $FATE on [---] and start of the pivotal in H2. Good data on [---] (solid tumor) will be awesome but I am managing my expectations. 7) SANA IND and data from 1st patient for [---] (T1D) 8) $IPSC IND for [---] (T1D) and some NHP data. 9) Update from $LCTX on OpRegen pivotal trial and scaling production of islet cells 10) Initial data from $ABSI on [---] (hair loss) https://twitter.com/i/web/status/2018369880937119987 https://twitter.com/i/web/status/2018369880937119987"  
[X Link](https://x.com/JessieChimni/status/2018369880937119987)  2026-02-02T17:04Z [----] followers, [---] engagements


"These hypo immune edits are very similar to $IPSC Allo Evasion [---] edits. $IPSC has progressed to Allo Evasion [---] and ccording to Chad Cowan over expression of HLA-E (ver 1.0) provides protection from 50% of the NK cells and not all types of NK cells. I was wondering how $LCTX would progress with this HIP in T1D. It will be good to get more insight from Brian I plan to share a comparative of HIP across $SANA $IPSC $CRSP and $LCTX over the next few days. https://twitter.com/i/web/status/2019433856307450142 https://twitter.com/i/web/status/2019433856307450142"  
[X Link](https://x.com/JessieChimni/status/2019433856307450142)  2026-02-05T15:32Z [----] followers, [---] engagements


"@ny1972_47 @Mohamed42146618 Yup lets see the efficacy and durability data for the other patients who were given Benda. Unfortunately there are only [--] total. I assume we will know more at EULAR [----] in June"  
[X Link](https://x.com/JessieChimni/status/2020522250470842540)  2026-02-08T15:36Z [----] followers, [--] engagements


"Looking forward to $CRSP and $LLY data update on Zugo-cel"  
[X Link](https://x.com/anyuser/status/2020615644937592960)  2026-02-08T21:48Z [----] followers, [---] engagements


"I had Claude assemble a table for the AID programs I am tracking across many companies : $FATE $CRSP $CABA $ALLO $ACET https://claude.ai/share/2c3a80cc-8181-448b-87f3-21228cf23da6 https://claude.ai/share/2c3a80cc-8181-448b-87f3-21228cf23da6"  
[X Link](https://x.com/JessieChimni/status/1989806239786918272)  2025-11-15T21:22Z [----] followers, [----] engagements


"Something interesting is brewing at $IPSC. I assume it has something to do with [---] (T1D). Starting an IST Good progress on IND 🤔"  
[X Link](https://x.com/JessieChimni/status/2008952703939227658)  2026-01-07T17:23Z [----] followers, [----] engagements


"$VRTX/ $CRSP - Casgevy exceeded $100 m revenue target in FY [----]. $VRTX will provide [----] revenue guidance in February"  
[X Link](https://x.com/JessieChimni/status/2011177825957769387)  2026-01-13T20:45Z [----] followers, [----] engagements


"Here is an updated snapshot of my #Genomics portfolio in Jan [----]. $IPSC is the only new addition. Change in % allocation is primarily due to relative over/underperformance of various companies. This only includes my stock positions. I am at 100% of my $ allocation to this portfolio & no future additions planned. I believe the removal of FDA hold on $NTLA [----] is a matter of time. Based on todays update at JPM I am confident that it will be removed and the trial will be allowed to continue enrollment. I generally add LEAPs closer to BLA/FDA approval. I have some $NTLA LEAPs which are not"  
[X Link](https://x.com/JessieChimni/status/2011516026777895164)  2026-01-14T19:09Z [----] followers, [----] engagements


"Interesting climb continues in $IPSC. The fact that they managed to get funding thru potentially [----] with the $2.6 warrants seems to give rest of the investors confidence. Now the next step is getting some NHP data sometime this year and human data next year. 🤞"  
[X Link](https://x.com/JessieChimni/status/2011858514701136209)  2026-01-15T17:50Z [----] followers, [---] engagements


"After doing enough research I have come to a conclusion that all iPSC derived T1D treatments will have a scaling problem to be commercially viable unless they address the islet cell expansion limitation. This impacts $SANA (451) $CRSP (213) $IPSC (813) and $VRTX. $LCTX is the only one that has discussed an approach to addressing the problem. Looking forward to their q4 update https://twitter.com/i/web/status/2011918686521823680 https://twitter.com/i/web/status/2011918686521823680"  
[X Link](https://x.com/JessieChimni/status/2011918686521823680)  2026-01-15T21:49Z [----] followers, [----] engagements


"@GeneInvesting [--] $FATE [---] start of pivotal trial in H2 [----] [--] $SANA [---] IND and start of CT in T1D 13) $LCTX OpRegen - potential start of pivotal in [----] 14) ACET - Start of pivotal for [---] (AID) in H2 [----] 15) $IPSC & $CRSP Start of clinical trial in T1D in 2027"  
[X Link](https://x.com/JessieChimni/status/2015908399087813039)  2026-01-26T22:03Z [----] followers, [---] engagements


"@_OliverVenture Look into $FATE and $IPSC"  
[X Link](https://x.com/JessieChimni/status/2016606998658502691)  2026-01-28T20:19Z [----] followers, [---] engagements


"Market opportunity identified by $CRBU for [---] in MM. $FATE [---] will also start an IST in MM and it does not require chemo. Looking forward to the data 🤞🤞 The TAM doubles if you add EU5 Canada Japan and Australia"  
[X Link](https://x.com/JessieChimni/status/2017076411782353146)  2026-01-30T03:24Z [----] followers, [----] engagements


"Do you know how many patients they can treat annually I follow $CABA only to understand the larger landscape but am not an investor. My biggest issue with autologous CAR-T is lack of scalability high COGs and high prices. In indications like SSC and Myositis the standard of care costs are very high so $CABA could be successful there until the allo CAR-T companies enter the same indications with lower COGs and higher scale assuming similar efficacy and durability. https://twitter.com/i/web/status/2018067276742963212 https://twitter.com/i/web/status/2018067276742963212"  
[X Link](https://x.com/JessieChimni/status/2018067276742963212)  2026-02-01T21:01Z [----] followers, [---] engagements


"@thecellengineer @AscendingBio @Octopusking77 Both $FATE and $ACET should be starting a pivotal for SLE/LN in H2 2026"  
[X Link](https://x.com/JessieChimni/status/2018170046816878720)  2026-02-02T03:50Z [----] followers, [---] engagements


"@GeneInvesting Anthony you think $BEAM will partner their SCD drug closer to BLA filing with big Pharma May be $PFE It will bolster their BS and let big pharma do what they are best at"  
[X Link](https://x.com/JessieChimni/status/2018508947070820812)  2026-02-03T02:16Z [----] followers, [---] engagements


"@ny1972_47 @CtaMaga @vksandhumd Same site that conducted the $SANA IST for T1D"  
[X Link](https://x.com/JessieChimni/status/2019461340184690960)  2026-02-05T17:21Z [----] followers, [--] engagements


"$CRSP Zugo-cel Ph1 Data Suggest Durability in LBCL. Looking forward to additional data by YE [----] [--] ORR 90% CRR 70% at DL4 (600M cell dose). [--] CRs ongoing at 12-mo visit. 383% ORR (5/6) in patients who failed TCE"  
[X Link](https://x.com/anyuser/status/2020612294510858262)  2026-02-08T21:34Z [----] followers, [---] engagements


"$CRSP update on Zugo-cel (CTX 112) from their rheumatology study. [--] SLE patients in remission. First SLE patient in drug-free remission maintained at Month [--]. Allo CAR-Ts using CY/FLU will be more economically viable than auto CAR-Ts using CY/FLU. $CRSP COGs for Zugo-cel is $10000/patient"  
[X Link](https://x.com/anyuser/status/2020602997320175880)  2026-02-08T20:57Z [----] followers, [----] engagements


"@ny1972_47 @Mohamed42146618 I wonder which FLU free conditioning was used for the SSc patient. They shared that the the dose was DL2. If they plan to standardize on Benda it would make sense for them to use Benda in all the new patients"  
[X Link](https://x.com/JessieChimni/status/2020940079926218845)  2026-02-09T19:17Z [----] followers, [--] engagements


"Some additional information on $CRSP CAR-Ts from CITI conference that you may find beneficial: The biggest issue with Gen [--] CAR-Ts was exhaustion. While the cells persisted for a month they were getting exhausted by day [--]. They needed to increase potency and reduce exhaustion They conducted a very large screen and identified two synergistic potency edits Regnase-1 and TGFBR2. Regnase-1 was also identified by another company conducting a similar screen and also by Carl June the father of CAR-T Both CTX [---] and [---] are in dose escalation phase. They are at pertinent dose levels and are"  
[X Link](https://x.com/JessieChimni/status/1760505438163116340)  2024-02-22T03:22Z [----] followers, 17.7K engagements


"Wow $TSLA #FSD v12.3 incoming. Rollout to all FSD customers seems to be underway. Going to do some testing tomorrow"  
[X Link](https://x.com/JessieChimni/status/1768514514692239624)  2024-03-15T05:48Z [----] followers, 12.8K engagements


"Nearly 100% energy self-sufficient with $TSLA solar powerwall + Tesla cars"  
[X Link](https://x.com/JessieChimni/status/1770916603221496050)  2024-03-21T20:53Z [----] followers, [----] engagements


"Update from Needham Healthcare Conference April [--] [----] This $CRSP update was more holistic and covered SCD Immuno Oncology Auto-Immune and Cardiovascular in-vivo Initiatives. Documenting these calls helps me better understand the science and the competitive landscape. $CRSP has [--] different trials underway and will grow from being a company that has [--] commercialized asset to many assets. He emphasized that scale is needed in cell & gene therapies. He highlighted their capital efficiency stating that with $400-$500 million in annual spend across four verticals they spend less than half of what"  
[X Link](https://x.com/JessieChimni/status/1779397449297367415)  2024-04-14T06:33Z [----] followers, 12K engagements


"Steve Harr CEO of $SANA had mentioned in the past that when it comes to autoimmune it will not be "first to market" but "first to scale" that will be important. According to Steve with [---] manufacturing runs of autologous CAR-T you will at best treat [---] patients. With [---] SC291 manufacturing runs $SANA can treat [-----] patients (assumed dose of [--] million cells) I believe this same logic is applicable to other allo CAR-T companies as well. # of patients treated will depend on their dose and output of a production run. Assuming allo CAR-Ts can deplete B cells as effectively as auto CAR-Ts allo"  
[X Link](https://x.com/JessieChimni/status/1780497321970589741)  2024-04-17T07:23Z [----] followers, [----] engagements


"Three slides from $SANA corporate deck that tell the story regarding the autoimmune opportunity: 1) TAM is large and spans [--] different diseases 2) B cell depletion appears to re-set the immune system within [--] months 3) $SANA SC291 is a effective in depleting B cells though we need to get data for three month efficacy/durability. Current average annual cost for SLE patients ranges between 13K for those with mild SLE $28K for moderate SLE and 68K for severe SLE patients. Lets assuming an average cost of $35K/year/patient. Since it is a [--] time treatment assume they can charge 5x of an annual"  
[X Link](https://x.com/JessieChimni/status/1781943681169182773)  2024-04-21T07:10Z [----] followers, 10.2K engagements


"@freshjiva Dont overlook $TSLA Energy. Thats also ramping 🤞"  
[X Link](https://x.com/JessieChimni/status/1792324065853833474)  2024-05-19T22:38Z [----] followers, [----] engagements


"@amitisinvesting As Ron Baron said - You cannot renege on a contract that majority of shareholders approved after he has delivered. Thats unethical"  
[X Link](https://x.com/JessieChimni/status/1799459712989343982)  2024-06-08T15:13Z [----] followers, [----] engagements


"I do not think I have spent more time documenting any other update as I have done for this $VERV update by @skathire at Goldman Sachs 45th Annual Global Healthcare Conference. It took longer because there were a lot of technical details and I wanted to understand/capture all. Additionally this was the most comprehensive update provided by Sek. I still need him to cover what the payers are willing to pay understanding that it is not multi-million $s and the COGs are similar to a mRNA vaccines. I like the fact Lilly has partnered with $VERV. It helps validate the science company and the market"  
[X Link](https://x.com/JessieChimni/status/1804579898859905443)  2024-06-22T18:19Z [----] followers, [----] engagements


"I drove FSD 12.5.1.5 today in multiple areas in Pleasanton and Livermore CA. I really did not experience what @WholeMarsBlog and others have been experiencing. It has improved and is more confident but nothing close to the improvement others have been discussing. It did many unexpected things that it had not done before - stop in the middle of an interaction. I need to drive more but it has a long way to go. This seems more linear than exponential @CernBasher @bradsferguson @TeslaLarry"  
[X Link](https://x.com/anyuser/status/1829338846674436265)  2024-08-30T02:02Z [----] followers, 21.8K engagements


"@SawyerMerritt They should give a 3-6 month free trial after V13 is released. It takes time for people to use it and once they use it takes time to start enjoying it and start getting used to it. [--] day trial is not enough"  
[X Link](https://x.com/JessieChimni/status/1849822634923729052)  2024-10-25T14:37Z [----] followers, [----] engagements


"$NTLA - I agree with @CathieDWood"  
[X Link](https://x.com/JessieChimni/status/1850257192508928208)  2024-10-26T19:24Z [----] followers, [----] engagements


"$CRSP update by @CrisprSam at Guggenheim Healthcare Innovation Conference Nov [--] [----]. I really liked the update happy reading"  
[X Link](https://x.com/JessieChimni/status/1857504766777241849)  2024-11-15T19:23Z [----] followers, [----] engagements


"$SANA and Steve Harr may actually come thru on this T1D. Congrats to all the holders. This is excellent news. Looking forward to the call at 1:30 PM https://ir.sana.com/news-releases/news-release-details/sana-biotechnology-announces-positive-clinical-results-type-1 https://ir.sana.com/news-releases/news-release-details/sana-biotechnology-announces-positive-clinical-results-type-1"  
[X Link](https://x.com/JessieChimni/status/1876741660580729195)  2025-01-07T21:24Z [----] followers, [----] engagements


"I have heard the $SANA UP421 call a couple of times and I am bothered by a the dose used in the patient: 1) If the patient only got 2%-7% of the islets required to make him insulin independent what will happen to the patient now Will he continue to stay on insulin 2) Was his T1D not severe enough to need a full cadaveric islet implant and he volunteered only for the safety study 3) Is this the reason they struggled to find patients to enroll 4) Had they done a full transplant since they have an anti-CD47 antibody they could have killed the cells if something had gone wrong. Just thinking out"  
[X Link](https://x.com/JessieChimni/status/1877072535843700982)  2025-01-08T19:19Z [----] followers, [----] engagements


"I really liked the $SANA update at JPM. Their biggest challenge now is funding. This is not an investment for people looking to make a quick buck next quarter. It will be a very turbulent ride that may have a good ending. NFA. I hope they are able to find non-dilutive financing through one of more partnerships. T1D - While the immune evasion risk is over they still need to figure out making the beta cells at the right level of "purity potency and yield" for commercialization. I see this as the next big challenge for them. AID - They are parallel tracking two initiatives. The ex-vivo CAR-T"  
[X Link](https://x.com/JessieChimni/status/1879598079441285472)  2025-01-15T18:34Z [----] followers, 12.8K engagements


"The investing world still does not understand that one time gene edited treatments and & cell therapies will become pervasive over the next [--] years ( $NTLA $CRSP $BEAM $VERV $FATE $SANA $LCTX $IPSC etc.) and payers will be paying for them because the value proposition is great. I have yet to see a failed treatment lately among the companies I track granted that they have had to go through multiple iterations to improve the efficacy/safety of the treatment ($CRSP: [---] to [---] $FATE: [---] to [---] VERV: [---] to 102). This space imo is closer to tech (build MVP and then iterate) than traditional"  
[X Link](https://x.com/JessieChimni/status/1902414309449462119)  2025-03-19T17:38Z [----] followers, [----] engagements


"@AndrewYang Not a bad idea. Then the Dems can come bk to the center"  
[X Link](https://x.com/JessieChimni/status/1903590816481968542)  2025-03-22T23:33Z [----] followers, 22.1K engagements


"@kylaschwaberow China insurance numbers $TSLA BREAKING: Tesla China insured units Mar [----] 3-9 : [-----] 10-16 : [-----] 17-23 : [-----] 24-30 : [-----] 🔥🔥🔥🔥 https://t.co/lBQj7MU1Dn $TSLA BREAKING: Tesla China insured units Mar [----] 3-9 : [-----] 10-16 : [-----] 17-23 : [-----] 24-30 : [-----] 🔥🔥🔥🔥 https://t.co/lBQj7MU1Dn"  
[X Link](https://x.com/JessieChimni/status/1906920704303673754)  2025-04-01T04:04Z [----] followers, [----] engagements


"I did some back of the envelop projection for $CRSP by 2030ish. The numbers can get a bit nutty however we need data for most of their pipeline. This should change by YE [----] I am very uncertain of their Autoimmune and solid tumor programs so I have clubbed all of oncology/autoimmune together. T1D has potential and significant upside but that is the second program I do not have significant confidence in. The ASCVD programs drive the bulk of the potential. The in-vivo SCD program is not included. The good part is that they should have minimal dilution. They should be break-even by [----] and"  
[X Link](https://x.com/JessieChimni/status/1910485253111898514)  2025-04-11T00:09Z [----] followers, [----] engagements


"$CRSP $VRTX update on CASGEVY: "Since launch through May 1st Vertex has activated more than [--] authorized treatment centers (ATCs) globally and approximately [--] patients have had their first cell collection." [--] new patients this quarter I believe. I hope the pace continues through the rest of the year. $VRTX adding additional manufacturing capacity is a good sign as well. "CASGEVY for the treatment of sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) CASGEVY is a non-viral ex vivo CRISPR/Cas9 gene-edited cell therapy for eligible patients with SCD or TDT that has"  
[X Link](https://x.com/JessieChimni/status/1919486951687913543)  2025-05-05T20:18Z [----] followers, [----] engagements


"If you cannot see and believe in the future of Gene Editing you may miss one of the largest investing opportunities. None of the #CRISPR gene editing companies ( $NTLA $CRSP $BEAM $VERV) have reported bad data. None (Excluding Oncology where efficacy and durability still needs to be proven). They represent the new #DigitalAge of treating root cause of diseases. I see no reason for them not to be approved by the FDA (FDA appointments/processes will get sorted out). The data is great and if they achieve the right level of efficacy in phase [--] they will have similar result in phase [--]. Furthermore"  
[X Link](https://x.com/JessieChimni/status/1920196107533226263)  2025-05-07T19:16Z [----] followers, [----] engagements


"Had a very good meeting at $FATE. Met Bob V CEO and Bill the chairman of the board. I will share my notes over the next few days. I will have to make this an annual trip"  
[X Link](https://x.com/JessieChimni/status/1928140757669405144)  2025-05-29T17:25Z [----] followers, [----] engagements


"Two #Genomic companies $CRSP and $NTLA have indicated that they should breakeven in [----]. Two others $FATE and $ARCT could also get there in [----] if not [----] itself. Hopefully this should start a recovery from this #BiotechWinter 🤞"  
[X Link](https://x.com/anyuser/status/1929565598352044263)  2025-06-02T15:47Z [----] followers, [----] engagements


"I had a great meeting with Bob Valamehr CEO and Bill Rastetter Chairman of the Board at the $FATE annual shareholder meeting. Bill met me at the reception after all the shareholder/ID verification http://x.com/i/article/1930270655846772736 http://x.com/i/article/1930270655846772736"  
[X Link](https://x.com/JessieChimni/status/1930276090205089815)  2025-06-04T14:50Z [----] followers, 10.3K engagements


"@ny1972_47 @mdurgin1 From a competitor landscape pov other CAR-Ts will still be competitors given that $FATE may not have enough supply of [---]. This of course assumes [---] achieves DORIS in both the arms. This is a big assumption as of now"  
[X Link](https://x.com/JessieChimni/status/1933942354622497204)  2025-06-14T17:39Z [----] followers, [---] engagements


"Current #Genomics portfolio based on todays price. Extremely disappointed with the $VERV acquisition for cents on a $. I guess Lilly also liked my back of the envelop math 😉 They acquired a potential [---] bagger for [--]. I hope the same does not happen to the rest of these companies. If it does that will be extremely disappointing. 😢"  
[X Link](https://x.com/JessieChimni/status/1934989562096533509)  2025-06-17T15:00Z [----] followers, [----] engagements


"I am extremely disappointed with the $VERV acquisition today. The IPO price was $19 and the valuation was $876 m. The company got sold for $800 m net of cash (it has $500 m in cash) including $300 m in milestone payment. Lilly is the winner here and all $VERV shareholders lost the opportunity to participate in any upside. Unfortunately $VERV operated as an outsourced R&D project for Lilly and they bought it after the tech/platform was de-risked with [---]. A company should not go public if there are no plans to achieve the potential of the opportunity. #Disappointing"  
[X Link](https://x.com/JessieChimni/status/1935055010506883348)  2025-06-17T19:20Z [----] followers, 17.4K engagements


"@strengthPlan Thats a launch/promotion price"  
[X Link](https://x.com/anyuser/status/1936908268208816546)  2025-06-22T22:04Z [----] followers, [----] engagements


"@amitisinvesting Wow. Sell $TSLA 😳. This will not age well 😉"  
[X Link](https://x.com/JessieChimni/status/1975250300480241977)  2025-10-06T17:22Z [----] followers, [----] engagements


"SS underway in $NTLA 🤔🚀 I did not expect this one but I am not complaining 😂"  
[X Link](https://x.com/JessieChimni/status/1975957087730766321)  2025-10-08T16:10Z [----] followers, [----] engagements


"Anthony is keeping the stock up @GeneInvesting $NTLA"  
[X Link](https://x.com/JessieChimni/status/1976304302026318316)  2025-10-09T15:10Z [----] followers, [----] engagements


"Still waiting for update from @CrisprSam on [---] and [---] (T1D). Hopefully $CRSP will provide an update in Q1 [----]. It will be great if they can start by sharing their HIP edits and some pre-clinical data similar to $IPSC"  
[X Link](https://x.com/JessieChimni/status/2007260216853991470)  2026-01-03T01:18Z [----] followers, [----] engagements


"@ablidy $SANA and $IPSC have shared their edits and Sana has tested them in humans in IST"  
[X Link](https://x.com/JessieChimni/status/2010790021855682922)  2026-01-12T19:04Z [----] followers, [---] engagements


"Nothing really new in the $SANA update at JPM [----]. Steve reiterated that they will file IND for SC451 this year and will also start the trial this year. The manufacturing is ready to support the Phase [--] trial but a lot of scientific work is yet to be done to support a commercial launch. My post on $LCTX refers to the challenges $SANA and others are facing. I am looking forward to $LCTX update to hear about their progress. https://x.com/JessieChimni/status/1989865383134900541s=20 https://x.com/JessieChimni/status/1989865383134900541s=20"  
[X Link](https://x.com/JessieChimni/status/2011546794510204969)  2026-01-14T21:11Z [----] followers, [---] engagements


"Wow #Genomic stocks are on the move. $NTLA moving faster than I expected"  
[X Link](https://x.com/JessieChimni/status/2014365451690922005)  2026-01-22T15:52Z [----] followers, [----] engagements


"RT @NextTradeX: $FATE PT $6 currently trades at $1.18"  
[X Link](https://x.com/anyuser/status/2015992400989323684)  2026-01-27T03:36Z [----] followers, [--] engagements


"RT @GeneInvesting: I think people arent realizing that its extremely unlikely the [--] year old patient wouldve crossed into Hys Law if t"  
[X Link](https://x.com/JessieChimni/status/2015996065489813955)  2026-01-27T03:51Z [----] followers, [--] engagements


"RT @SawyerMerritt: Tesla FSD v14.2.2.4 counter-steers after sliding"  
[X Link](https://x.com/JessieChimni/status/2015997637619802353)  2026-01-27T03:57Z [----] followers, [---] engagements


"RT @landon20s: I spy a @robotaxi in Chicago 🤖"  
[X Link](https://x.com/JessieChimni/status/2016025192489975889)  2026-01-27T05:47Z [----] followers, [---] engagements


"RT @_SFTahoe: FALSE NARRATIVE: No insurer wants to ensure RoboTaxis. FACTS: Lemonades autonomous insurance live in Arizona. Smart"  
[X Link](https://x.com/JessieChimni/status/2016025557985853649)  2026-01-27T05:48Z [----] followers, [--] engagements


"FDA decision to remove the hold on $NTLA [----] CM should not be that far. 🤞🤞 🚨🚨WOW $NTLA has announced that the FDA has removed the clinical hold placed on the Investigational New Drug application (IND) for its MAGNITUDE-2 Phase [--] clinical trial of nex-z 🧵👇 for patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN). A https://t.co/XNsxrJ0NiG 🚨🚨WOW $NTLA has announced that the FDA has removed the clinical hold placed on the Investigational New Drug application (IND) for its MAGNITUDE-2 Phase [--] clinical trial of nex-z 🧵👇 for patients with hereditary"  
[X Link](https://x.com/JessieChimni/status/2016178744801849592)  2026-01-27T15:57Z [----] followers, [----] engagements


"RT @GeneInvesting: I want to take this opportunity to apologize to ABSOLUTELY NOBODY. $NTLA Being short here is idiotic. Less than [--] mont"  
[X Link](https://x.com/anyuser/status/2016179200433259006)  2026-01-27T15:59Z [----] followers, [--] engagements


"RT @LimitingThe: https://youtu.be/XBXAQFJhg-M https://youtu.be/XBXAQFJhg-M"  
[X Link](https://x.com/anyuser/status/2016183373706953190)  2026-01-27T16:15Z [----] followers, [--] engagements


"@GeneInvesting @RNAiAnalyst I have sold $45 $BEAM Jan [----] CCs for $6. Breakeven is $51. If it stays below $45 by expiry I pocket $6 otherwise the shares get called away. I will re-assess re-entry later"  
[X Link](https://x.com/JessieChimni/status/2016382624261111843)  2026-01-28T05:27Z [----] followers, [---] engagements


"RT @BrianFeroldi: Investing & the Dunning-Kruger effect. I'm 100% guilty of this"  
[X Link](https://x.com/JessieChimni/status/2016391029856075878)  2026-01-28T06:00Z [----] followers, [--] engagements


"RT @readswithravi: Morgan Housel on the highest form of wealth:"  
[X Link](https://x.com/JessieChimni/status/2016391140854136886)  2026-01-28T06:01Z [----] followers, [---] engagements


"RT @davidasinclair: The fascinating race to reprogram humans @techreview https://www.technologyreview.com/2026/01/27/1131796/the-first-human-test-of-a-rejuvenation-method-will-begin-shortly/ https://www.technologyreview.com/2026/01/27/1131796/the-first-human-test-of-a-rejuvenation-method-will-begin-shortly/"  
[X Link](https://x.com/JessieChimni/status/2016391437466927713)  2026-01-28T06:02Z [----] followers, [--] engagements


"@CtaMaga @vksandhumd Interesting site. Thats where $SANA UP421 IST was executed"  
[X Link](https://x.com/JessieChimni/status/2016624894411469252)  2026-01-28T21:30Z [----] followers, [--] engagements


"RT @LimitingThe: From Tesla Q4 Slide Deck: "We now produce dry-electrode for [----] cells with both anode and cathode made in Austin.""  
[X Link](https://x.com/JessieChimni/status/2016636013385564500)  2026-01-28T22:14Z [----] followers, [--] engagements


"RT @TashaARK: If @Tesla has [---] robotaxis and doubles the fleet every month it could surpass Waymo's fleet in 3-4 months. Last we saw Waym"  
[X Link](https://x.com/JessieChimni/status/2016650412221501539)  2026-01-28T23:11Z [----] followers, [---] engagements


"RT @munster_gene: $TSLA shares pull back slightly on CFO comment auto margins will be impacted as they switch the accounting of full purcha"  
[X Link](https://x.com/JessieChimni/status/2016685692122980570)  2026-01-29T01:31Z [----] followers, [--] engagements


"Market opportunity identified by $CRBU for [---] in MM. $FATE [---] will also start an IST in MM and it does not require chemo. Looking forward to the data 🤞🤞"  
[X Link](https://x.com/JessieChimni/status/2017070232058417551)  2026-01-30T02:59Z [----] followers, [--] engagements


"RT @BillAckman: If @elonmusk can bring sight to the blind it will outdo every one of his near-miraculous achievements to date. With all"  
[X Link](https://x.com/JessieChimni/status/2017071626412839277)  2026-01-30T03:05Z [----] followers, [----] engagements


"RT @TheSonOfWalkley: BREAKING: $TSLA RECEIVES APPROVAL FOR FULL SELF-DRIVING TESTS IN SWEDEN 👀 FSD is coming to Europe"  
[X Link](https://x.com/JessieChimni/status/2017076753186111756)  2026-01-30T03:25Z [----] followers, [---] engagements


"RT @jasondebolt: If theres going to be a SpaceX IPO a lot of $TSLA investors are going to sell some stock to get in on it. Elon will have"  
[X Link](https://x.com/JessieChimni/status/2017111463098486853)  2026-01-30T05:43Z [----] followers, [---] engagements


"RT @yaireinhorn: 1/🚨WOW Eli Lilly is increasing its leading position in the CRISPR and Gene Editing field by establishing another interest"  
[X Link](https://x.com/JessieChimni/status/2017287578962235472)  2026-01-30T17:23Z [----] followers, [--] engagements


"@GeneInvesting People want instant gratification. The CRISPR journey will take some time to play out and people dont have the patience. The data continues to improve and valuations continue to suck. This is not for the faint of heart"  
[X Link](https://x.com/JessieChimni/status/2017314695452209216)  2026-01-30T19:11Z [----] followers, [---] engagements


"$TSLA #Genomics Only buy something that youd be perfectly happy to hold if the market shut down for [--] years. - Warren Buffett https://t.co/3FoVRzQ9Z8 Only buy something that youd be perfectly happy to hold if the market shut down for [--] years. - Warren Buffett https://t.co/3FoVRzQ9Z8"  
[X Link](https://x.com/JessieChimni/status/2017350333094330559)  2026-01-30T21:32Z [----] followers, [---] engagements


"@yaireinhorn @collision @skathire @bradloncar @BiotechCH @davidrliu @EliLillyandCo @BioStocks @Stocktwits @Maximus_Holla @BrandonVanZee IMHO these are generational opportunities which most will miss"  
[X Link](https://x.com/JessieChimni/status/2017714414942884105)  2026-01-31T21:39Z [----] followers, [--] engagements


"Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference - GlobeNewswire Lets see what $IPSC presents tomorrow 🤞 https://stocks.apple.com/AqHt30f6jRsiFz2x-YKbsSw https://stocks.apple.com/AqHt30f6jRsiFz2x-YKbsSw"  
[X Link](https://x.com/JessieChimni/status/1772435850401632282)  2024-03-26T01:30Z [----] followers, [---] engagements


"At the Piper Sandler 37th Annual Healthcare Conference there was a panel discussion titled "State of the Art in Cell Therapy." Interestingly the primary participants engaged in this discussion were: 1) Fate Therapeutics ($FATE): Dr. Bob Valamehr CEO 2) Century Therapeutics ($IPSC): Represented by Dr. Chad Cowan Chief Scientific Officer. Unfortunately a recording of this session is not available. This would have been a great session to hear. The presence of both Fate and Century on the same panel is interesting because they are the two primary publicly traded leaders in the iPSC-derived"  
[X Link](https://x.com/JessieChimni/status/1996035248870875137)  2025-12-03T01:54Z [----] followers, [----] engagements


"$FATE illustration of the difference between their "Off the Shelf" CAR-Ts and other allo CAR-Ts:"  
[X Link](https://x.com/JessieChimni/status/1945567889010167850)  2025-07-16T19:35Z [----] followers, [----] engagements


"@alc2022 $FATE and $CRSP assuming both report good data over the next 6-12 months"  
[X Link](https://x.com/JessieChimni/status/1947674122475245643)  2025-07-22T15:04Z [----] followers, [----] engagements


"@ny1972_47 Hmmmm"  
[X Link](https://x.com/JessieChimni/status/1978123395469287852)  2025-10-14T15:39Z [----] followers, [---] engagements


"A good directionally correct Q3 update from $CRSP. 1) Good data on [---] but it is still very early. I wonder why they moving into a 1b trial instead of initiating a phase [--]. What have they seen on the safety front 🤔 [---] Lp(a) update will be in H2 as they had stated earlier 2) They will provide a "broad" update on [---] in AID and Oncology. Let's see how this goes. Their solid tumor ambitions seem to have ended with discontinuation of [---]. I had expected this. Let's see if this is end of the road or they have a new iteration/platform for solid tumors in the pipe. 3) No mention of [---] in their"  
[X Link](https://x.com/JessieChimni/status/1987939858590085261)  2025-11-10T17:46Z [----] followers, [----] engagements


"@ny1972_47 @mdurgin1 🎯 Thats always been on my mind. They definitely learnt a lot and realized that they needed the potency of a (alpha beta) T cell. By then they also progressed with Sword & Shield tech. 🤞🤞"  
[X Link](https://x.com/JessieChimni/status/2001529120367448277)  2025-12-18T05:45Z [----] followers, [--] engagements


"New corporate update $IPSC: Lots of emphasis on [---]. IND in [----] with clinical data in [----]. They have not discussed their current manufacturing capacity/cost. That's an important area I am tracking. Lots of good details on the differentiation process. I think they are a year behind $SANA and probably at the same stage as $CRSP (213) with regards to iPSC derived islet cells. $CRSP may have an advantage because they have tested the Hypoimmune edits in [--] humans in the [---] CT. https://investors.centurytx.com/static-files/0187ee20-4fa2-442d-bb08-681017ce2521"  
[X Link](https://x.com/JessieChimni/status/2011281464134881457)  2026-01-14T03:37Z [----] followers, [---] engagements


"@TeslaBoomerMama I would prefer the software like margins from FSD/RT to show up on $TSLA income statement without dilution. I like the SpaceX merger idea from the long term perspective. I dont like the short term (1-3 year) valuation impact"  
[X Link](https://x.com/JessieChimni/status/2017419005930381413)  2026-01-31T02:05Z [----] followers, [---] engagements


"I like the fact that Professors Georg Schett will be initiating the IIT but I don't understand the logic. Will the be running two trials testing the same thing or are the two trials targeting different AIDs https://investors.centurytx.com/news-releases/news-release-details/century-therapeutics-announces-investigator-initiated-phase-12 https://investors.centurytx.com/news-releases/news-release-details/century-therapeutics-announces-investigator-initiated-phase-12"  
[X Link](https://x.com/JessieChimni/status/1882319004829966388)  2025-01-23T06:46Z [----] followers, [---] engagements


"$SANA Sana Biotechnology Inc. announced an upcoming podium presentation showcasing clinical data from a groundbreaking study involving the transplantation of UP421 an engineered allogeneic primary islet cell therapy into a type [--] diabetes patient without immunosuppression. This presentation will occur at the joint American Diabetes Association (ADA) and International Pancreas & Islet Transplant Association (IPITA) symposium during the 85th Annual ADA Scientific Sessions in Chicago from June 20-23 [----]. The presentation titled "Hypoimmune Pancreatic Islet Transplantation in Adult Subjects with"  
[X Link](https://x.com/JessieChimni/status/1932341743007236438)  2025-06-10T07:39Z [----] followers, [----] engagements


"@yaireinhorn @TohJah7809 💯🎯. I really like how $VERV (used to) and $BEAM provide their data updates. $CRSP needs to learn from them"  
[X Link](https://x.com/JessieChimni/status/2004951793139417252)  2025-12-27T16:25Z [----] followers, [---] engagements


"I have been working on my [----] $TSLA price target. This is not investment advice; it is to illustrate how I am assessing the opportunity. I look at being directionally correct and NOT "precisely accurate/wrong". The model is not a based on bottoms-up calculation rather it uses aggregate volume & associated revenue/margin and uses a number of assumptions. I have developed three price targets: 1) Bear Case: $1000 2) Base Case: [----] & 3) Bull case: $3000. The model does not include #RoboTaxi nor #Optimus. Assumptions & projections are attached below:"  
[X Link](https://x.com/anyuser/status/1627174043056226304)  2023-02-19T05:11Z [----] followers, 40.9K engagements


"RT @HinrichsZane: In three years there are projected to be well over [------] of these on our highways"  
[X Link](https://x.com/anyuser/status/2021324309244019012)  2026-02-10T20:44Z [----] followers, [---] engagements


"In three years there are projected to be well over [------] of these on our highways"  
[X Link](https://x.com/anyuser/status/2020878936201449597)  2026-02-09T15:14Z 11.7K followers, 47.1K engagements


"RT @StockSavvyShay: $TSLA drivers in Oregon can now get up to a 50% insurance discount when using FSD (Supervised) through $LMND new autono"  
[X Link](https://x.com/anyuser/status/2021278940921303227)  2026-02-10T17:43Z [----] followers, [--] engagements


"$TSLA drivers in Oregon can now get up to a 50% insurance discount when using FSD (Supervised) through $LMND new autonomous insurance program. The more miles driven on FSD the lower the premium with broader state expansion planned"  
[X Link](https://x.com/anyuser/status/2021248334007013421)  2026-02-10T15:42Z 347.2K followers, 28.4K engagements


"RT @yaireinhorn: 1/🚨WOW $CRBU has presented updated clinical data from @CaribouBio ongoing CB-011 CaMMouflage phase [--] clinical trial in ca"  
[X Link](https://x.com/anyuser/status/2020872894398812360)  2026-02-09T14:50Z [----] followers, [--] engagements


"1/🚨WOW $CRBU has presented updated clinical data from @CaribouBio ongoing CB-011 CaMMouflage phase [--] clinical trial in cancer patients with relapsed or refractory multiple myeloma (r/r MM). The CB-011 CaMMouflage phase [--] translational and clinical data - which was presented at the [----] Tandem Meetings of ASTCT and CIBMTR demonstrated deep and durable responses and further support the potential of CB-011 as the best-in-class allogeneic CAR-T Cell Therapy for second-line relapsed or refractory multiple myeloma patients. $XBI 🧵👇 https://twitter.com/i/web/status/2020850523788673400"  
[X Link](https://x.com/anyuser/status/2020850523788673400)  2026-02-09T13:21Z 18.5K followers, 11.9K engagements


"$CRSP Zugo-cel Ph1 Data Suggest Durability in LBCL. Looking forward to additional data by YE [----] [--] ORR 90% CRR 70% at DL4 (600M cell dose). [--] CRs ongoing at 12-mo visit. 383% ORR (5/6) in patients who failed TCE"  
[X Link](https://x.com/anyuser/status/2020612294510858262)  2026-02-08T21:34Z [----] followers, [---] engagements


"Looking forward to $CRSP and $LLY data update on Zugo-cel"  
[X Link](https://x.com/anyuser/status/2020615644937592960)  2026-02-08T21:48Z [----] followers, [---] engagements


"$CRSP update on Zugo-cel (CTX 112) from their rheumatology study. [--] SLE patients in remission. First SLE patient in drug-free remission maintained at Month [--]. Allo CAR-Ts using CY/FLU will be more economically viable than auto CAR-Ts using CY/FLU. $CRSP COGs for Zugo-cel is $10000/patient"  
[X Link](https://x.com/anyuser/status/2020602997320175880)  2026-02-08T20:57Z [----] followers, [----] engagements


"RT @india_plus_: 🚨India underestimates how advance it is in currency digitisation even developed nations struggle to keep pace with. - La"  
[X Link](https://x.com/anyuser/status/2020577985200554410)  2026-02-08T19:18Z [----] followers, [---] engagements


"🚨India underestimates how advance it is in currency digitisation even developed nations struggle to keep pace with. - Larry Fink BlackRock Chief Follow @india_plus_"  
[X Link](https://x.com/anyuser/status/2020490800166048223)  2026-02-08T13:32Z [----] followers, 121.2K engagements


"RT @mpmahida: Looking back If Tesla would not have replaced the heuristic algo with NN based FSD the stock would have been trading below 2"  
[X Link](https://x.com/anyuser/status/2020550222334595334)  2026-02-08T17:28Z [----] followers, [--] engagements


"Looking back If Tesla would not have replaced the heuristic algo with NN based FSD the stock would have been trading below [---] right now. Elons master stroke of survival and a leapfrog in physical AI"  
[X Link](https://x.com/anyuser/status/2020542846294536212)  2026-02-08T16:58Z [---] followers, [---] engagements


"RT @MashraniVivek: Corrections dont destroy wealth. Confusion does. One lesson from Peter Lynch stands tall: If earnings grow prices eve"  
[X Link](https://x.com/anyuser/status/2020305984552595802)  2026-02-08T01:17Z [----] followers, [--] engagements


"Corrections dont destroy wealth. Confusion does. One lesson from Peter Lynch stands tall: If earnings grow prices eventually follow. Stay focused on businesses not market moods. 👉 Share this with someone investing for the long term. #stockmarket #investor #wealth"  
[X Link](https://x.com/anyuser/status/2020105262045229309)  2026-02-07T12:00Z 111.5K followers, [----] engagements


"RT @CricketCentrl: 🚨 MASSIVE STATEMENT BY KEVIN PIETERSON ON VAIBHAV SOORYAVANSHI 🚨 "When I was watching Vaibhav Sooryavanshi bat it fel"  
[X Link](https://x.com/anyuser/status/2020024180927087017)  2026-02-07T06:37Z [----] followers, [---] engagements


"🚨 MASSIVE STATEMENT BY KEVIN PIETERSON ON VAIBHAV SOORYAVANSHI 🚨 "When I was watching Vaibhav Sooryavanshi bat it felt like a video game was going on. I am already predicting that he will become the best player of India. This boy will create such records which will be difficult to break in the future. Vaibhav Sooryavanshi's stormy innings of [---] runs completely eliminated England from the match." https://twitter.com/i/web/status/2019779497277480991 https://twitter.com/i/web/status/2019779497277480991"  
[X Link](https://x.com/anyuser/status/2019779497277480991)  2026-02-06T14:25Z [----] followers, 253.1K engagements


"RT @imVkohli: Congratulations to the U-19 Indian team for lifting the World Cup once again. Our domination in the age group cricket and bey"  
[X Link](https://x.com/anyuser/status/2019834404009615800)  2026-02-06T18:03Z [----] followers, 16.3K engagements


"Congratulations to the U-19 Indian team for lifting the World Cup once again. Our domination in the age group cricket and beyond continues. Well done to the whole squad and the support staff. 👏"  
[X Link](https://x.com/anyuser/status/2019792823814402374)  2026-02-06T15:18Z 66M followers, 1.9M engagements


"RT @_SFTahoe: Tesla RoboTaxis are safer than a human driver"  
[X Link](https://x.com/anyuser/status/2019815726803275957)  2026-02-06T16:49Z [----] followers, [--] engagements


"Tesla RoboTaxis are safer than a human driver. ZERO incidents in Austin so far this year @Tesla @Tesla_AI @robotaxi 💪 https://t.co/XHjt3avdUq https://t.co/ffw6PfqXP9 ZERO incidents in Austin so far this year @Tesla @Tesla_AI @robotaxi 💪 https://t.co/XHjt3avdUq https://t.co/ffw6PfqXP9"  
[X Link](https://x.com/_SFTahoe/status/2019767427060445656)  2026-02-06T13:37Z 21.7K followers, 13.1K engagements


"ZERO incidents in Austin so far this year @Tesla @Tesla_AI @robotaxi 💪 https://app.powerbigov.us/viewr=eyJrIjoiODAwNzM0OTYtNjdjZi00ZWFhLWI2MDItZDg1NmZiYTk3MjgxIiwidCI6IjVjNWUxOWY2LWE2YWItNGI0NS1iMWQwLWJlNDYwOGE5YTY3ZiJ9 https://app.powerbigov.us/viewr=eyJrIjoiODAwNzM0OTYtNjdjZi00ZWFhLWI2MDItZDg1NmZiYTk3MjgxIiwidCI6IjVjNWUxOWY2LWE2YWItNGI0NS1iMWQwLWJlNDYwOGE5YTY3ZiJ9"  
[X Link](https://x.com/anyuser/status/2019534173061730446)  2026-02-05T22:10Z [----] followers, 14.4K engagements


"RT @BastianBraun121: 🚨 BREAKING: Nancy Tengler says: IGNORE valuations Tesla is STILL a once-in-a-lifetime opportunity The real journe"  
[X Link](https://x.com/anyuser/status/2019674414238036006)  2026-02-06T07:27Z [----] followers, [---] engagements


"🚨 BREAKING: Nancy Tengler says: IGNORE valuations Tesla is STILL a once-in-a-lifetime opportunity The real journey is only just starting 🚀"  
[X Link](https://x.com/anyuser/status/2019392958383202609)  2026-02-05T12:49Z [----] followers, 50.8K engagements


"Increased my $FATE position by 10% today"  
[X Link](https://x.com/anyuser/status/2019582732289077406)  2026-02-06T01:23Z [----] followers, [---] engagements


"RT @NavalismHQ: "Never tweet in anger." @naval"  
[X Link](https://x.com/anyuser/status/2019513749921796360)  2026-02-05T20:49Z [----] followers, [--] engagements


""Never tweet in anger." @naval"  
[X Link](https://x.com/anyuser/status/2019489200056258673)  2026-02-05T19:12Z 541.6K followers, 12.6K engagements


"Great buying opportunity in #Genomics. May be tomorrow it will be even greater 😂"  
[X Link](https://x.com/anyuser/status/2019510802479489055)  2026-02-05T20:37Z [----] followers, [---] engagements


"Hopefully it can do the same for drafting BLAs #Genomics 🤞🤞"  
[X Link](https://x.com/anyuser/status/2019507345928384749)  2026-02-05T20:24Z [----] followers, [---] engagements


"RT @LineageCell: $LCTX has activated a second DOSED clinical study site for #OPC1 its allogeneic cell transplant therapy candidate for spi"  
[X Link](https://x.com/anyuser/status/2019077529152131181)  2026-02-04T15:56Z [----] followers, [--] engagements


"$LCTX has activated a second DOSED clinical study site for #OPC1 its allogeneic cell transplant therapy candidate for spinal cord injury at @RanchoResearchI in conjunction with their affiliated hospital @RanchoRehab where Charles Liu M.D. Ph.D. will serve as Principal Investigator. For more about Rancho Research Institute please visit: For more about Rancho Los Amigos National Rehabilitation Center please visit: For more about DOSED please visit: #ReplaceandRestore #ClinicalTrials #SCI #SpinalCordInjury https://bit.ly/45QJ0Ei https://bit.ly/4gmHBsI https://bit.ly/4qXSrKo"  
[X Link](https://x.com/anyuser/status/2019059671449879035)  2026-02-04T14:45Z [----] followers, [---] engagements


"RT @InvestingCanons: I did not succeed in life by intelligence. I succeeded because I have a long attention span. Charlie Munger https"  
[X Link](https://x.com/anyuser/status/2018935979537797401)  2026-02-04T06:33Z [----] followers, [---] engagements


"I did not succeed in life by intelligence. I succeeded because I have a long attention span. Charlie Munger"  
[X Link](https://x.com/anyuser/status/2018490117003034774)  2026-02-03T01:02Z 115K followers, 72K engagements


"$LCTX Green in a sea of red. OpRegen update around the corner 🤔"  
[X Link](https://x.com/anyuser/status/2018746236371939477)  2026-02-03T17:59Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing